revenuepatent

134 results found.

Top Stocks matching your search for "revenue patent"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 21, 2023

Close to generating revenue is only positive

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

$RSLS shows a strong growth in Revenue.

Feb, 18, 2023

$RSLS: The Revenue has been growing by 32.01% on a... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 22, 2023

$AUPH shows a strong growth in Revenue.

Mar, 22, 2023

Looking at the last year, $AUPH shows a very stron... See more

FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 21, 2023

Close to generating revenue is only positive

Mar, 21, 2023

$FSR Easy buy before revenue.

Mar, 20, 2023

$FSR shows a strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 19, 2023

Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. šŸ”„šŸŗ

Mar, 18, 2023

$FSR: The Revenue has grown by 232.04% in the past year.

Mar, 18, 2023

$FSR: The Revenue has grown by 232.04% in the past year.

Mar, 17, 2023

Revenue and a profitable ocean program is coming.

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

$RSLS shows a strong growth in Revenue.

Feb, 18, 2023

$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.

Feb, 8, 2023

$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.

Feb, 3, 2023

$RSLS: The Revenue has been growing by 32.01% on average over the past 5 years.

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 22, 2023

$AUPH shows a strong growth in Revenue.

Mar, 22, 2023

Looking at the last year, $AUPH shows a very strong growth in Revenue.

Mar, 19, 2023

Should be very easy to beat EOY guidance for product revenue.

Mar, 18, 2023

Looking at the last year, $AUPH shows a very strong growth in Revenue.

Mar, 16, 2023

Looking at the last year, $AUPH shows a very strong growth in Revenue.

Mar, 14, 2023

MC is aready high for revenues of 120-140 M per year.

Mar, 14, 2023

$AUPH: The Revenue has been growing by 204.93% on average over the past 5 years.

Mar, 9, 2023

$AUPH shows a strong growth in Revenue.

Mar, 9, 2023

$AUPH shows a strong growth in Revenue.

Mar, 8, 2023

$AUPH shows a strong growth in Revenue.